About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Metabolism, Circadian Rhythms and Ovarian Function

NCT05007834·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Pascal PIGNY, MD,PhD
CONTACT
0320445962 pascal.pigny@chru-lille.fr

Lead

University Hospital, Lille

Age

25–35

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Women with a chemotherapy-induced (CIA) amenorrhea who asked for post-cancer fertility follow-up at the University Hospital of Lille, France.
Women between 25 to 35 years age at inclusion
Chemotherapy protocol: FEC 100 (3 cycles) + docetaxel (3 cycles

You may not be if

Women without CIA
Women who refuse to participate in the study
Women older than 35 years at inclusion
Women who received another chemotherapy protocol

The record

StatusRecruiting

PhaseNo phase

Taking part50

StartedFeb 2022

UpdatedDec 26, 2025

Conditions

Chemotherapy-Induced Amenorrhea

Where1

Hop Jeanne de Flandre Chu Lille
Lille, France

Clareo Health | Metabolism, Circadian Rhythms and Ovarian Function